HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Net sales in Q4 were $65.5 mil., representing growth of about 3%, or 9% at comparable foreign currency exchange rates, Inter Parfums announces Jan. 17. For the year, net revenues were up 16% to $273.4 mil. At comparable foreign currency exchange rates, sales increased nearly 17%, company adds. Inter Parfums also affirms 2006 guidance, with net sales expected to grow 10% to approximately $301 mil., and net income projected to rise 16% to $16.9 mil. Company notes guidance assumes the dollar remains at current levels. Growth in the year will stem largely from "ambitious" product launch initiatives (1"The Rose Sheet" May 16, 2005, p. 5). Inter Parfums will release operating results for the 2005 fourth quarter around March 7...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel